Welcome to LookChem.com Sign In|Join Free
  • or
4-(3-bromoanilino)-7-ethoxy-6-methoxy-1,2,3-benzotriazine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1048698-75-4

Post Buying Request

1048698-75-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1048698-75-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1048698-75-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,8,6,9 and 8 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1048698-75:
(9*1)+(8*0)+(7*4)+(6*8)+(5*6)+(4*9)+(3*8)+(2*7)+(1*5)=194
194 % 10 = 4
So 1048698-75-4 is a valid CAS Registry Number.

1048698-75-4Downstream Products

1048698-75-4Relevant academic research and scientific papers

Synthesis and biological evaluation of substituted 1,2,3-benzotriazines and pyrido[3,2-d]-1,2,3-triazines as inhibitors of vascular endothelial growth factor receptor-2

Zhao, Xing-Wang,Liu, Dan,Luan, Sheng-Lin,Hu, Guo-Dong,Lv, Jin-Ling,Jing, Yong-Kui,Zhao, Lin-Xiang

, p. 7807 - 7815 (2014/01/06)

A novel series of substituted 1,2,3-benzotriazines and pyrido[3,2-d]-1,2,3- triazines were synthesized. The abilities of these compounds to inhibit the VEGFR-2 kinase activity and the proliferation of human microvascular endothelial cells (MVECs) were det

AROMATIC RING FUSED TRIAZINE DERIVATIVES AND USES THEREOF

-

Page/Page column 8-9, (2011/08/06)

The invention belongs to pharmaceutical field. The invention relates to the compounds according to Formula I, including their optically active forms, pharmaceutically acceptable salts or hydrates, and the pharmaceutical composition comprising thereof as a

THE AROMATIC RING TRIAZINE DERIVATIVES AND THE USES THEREOF

-

Page/Page column 12, (2010/12/01)

The invention belongs to pharmaceutical field. The invention relates to the compounds according to Formula I. including their optically active forms, pharmaceutically acceptable salts or hydrates, and the pharmaceutical composition comprising thereof as a

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1048698-75-4